APR Applied Pharma Research (“APR”) and Labtec GmbH (“Labtec”) announce the successful completion of the pivotal clinical study on Zolmitriptan RapidFilm®, and its upcoming submission for registration in Europe.

APR Applied Pharma Research (“APR”) and Labtec GmbH (“Labtec”) announce the successful completion of the pivotal clinical study on Zolmitriptan RapidFilm®, and its upcoming submission for registration in Europe.
Linkedin